March 25, 2026 CoC HS Treatment Considerations for Neuropsychiatric Manifestations of Alzheimer's Disease (pharmacists & technicians)
.jpg)
CONTINUING PHARMACY EDUCATION
Treatment Considerations for Neuropsychiatric Manifestations of Alzheimer's Disease
Speaker:
SPEAKER: Sunny Linnebur, PharmD, BCGP, BCPS, FCCP, FASCP, Professor, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical CampuAurora, CO
ACPE Universal Program ID# 0122-0000-26-031-H01-P/T
1 Contact Hours [0.1 CEU]
Release Date: March 25, 2026
Expiration Date: March 25, 2027
Fee
$0.00
CE Hours
1.00
CE Units
0.100
Activity Type
- Knowledge
Target Audience(s)
- Pharmacists and Pharmacy Technicians
Accreditation(s)
Premier, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Requirements for CE Credit
Treatment Considerations for Neuropsychiatric Manifestations of Alzheimer's Disease (pharmacists and technicians)
Treatment Considerations for Neuropsychiatric Manifestations of Alzheimer's Disease (pharmacists and technicians)
There are 2 steps to completing this home-study CE.
Step 1: Watch the video presentation in its entirety.
Step 2: Click on "Take the Test" to complete the post-test and evaluation.
Please Note: A handout is provided. Please print it out and follow along with the audio recording.
Objectives
- Discuss common neuropsychiatric manifestations of Alzheimer's Disease
- Identify FDA-approved options for treating agitation in persons with Alzheimer's Disease
- Outline additional medications that have been investigated for the treatment of agitation and psychosis in persons with Alzheimer's Disease
- Describe toxicities/adverse events associated with medications commonly utilized to treat neuropsychiatric manifestations of Alzheimer's Disease
Activity Number
0122-0000-26-031-H01-P/T
Release Date:
Mar 25, 2026
Credit Expiration Date:
Mar 25, 2027
CE Hours
1.00